Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹953.35
Market cap
₹8,645 Cr
Revenue (annual)
₹1,819 Cr
Net profit (annual)
₹174.7 Cr
P/E (TTM)
40.6×Sector 47.3×
Promoter holding
42.86%-0.22% QoQ
FII holding
8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:47 IST BSE
Board Meeting Date

Aarti Pharmalabs Board Meeting Date

Aarti Pharmalabs scheduled a Board Meeting for August 7, 2026. The board will consider and approve the unaudited financial results for the quarter ended June 30, 2026.

11:26 IST BSE
Board Meeting Date

Aarti Pharmalabs Board Meeting Date

Aarti Pharmalabs postponed its May 18 board meeting to May 25, 2026. The trading window remains closed until May 27 following financial results declaration.

15:09 IST BSE
Board Meeting Date

Aarti Pharmalabs Board Meeting Date

Aarti Pharmalabs scheduled a May 18, 2026 board meeting to approve FY26 results and final dividend. Investors should track these upcoming financial disclosures.